Invizius
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Bo'ness Newhouse Chapelhall Rd, Motherwe...Website
www.invizius.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Invizius
Invizius Limited is a late pre-clinical-stage biotechnology company developing treatments to suppress unwanted innate immune responses, focused initially on reducing the life-threatening inflammatory effects of dialysis.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Invizius your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Invizius is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Invizius
Product Launch: Get notified when Invizius launches new products
Check if Invizius has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Invizius recently announced quarterly report
Invizius, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Invizius has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Invizius had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Invizius
Compare insights from companies similar to Invizius, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Invizius
<$5M
11-50
Private
$8.6M
2017
N/A
Company Profile Activity
Activity Insights
Invizius is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Invizius is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Invizius.
Invizius financials insights
Gather financial insights about Invizius, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$7.4M
2024
Other Financing Round
$1.2M
Invizius Tech Stack
A closer look at the technologies used by Invizius
Invizius News & Media
Invizius Treats First Patients in First-In-Human Phase 1 Clinical Study of Lead Dialysis Product H-Guard®
First patients treated with H-Guard® at the National Institute for Health and Care Research Manchester Clinical Research Facility MHRA approves continuation of Invizius's first-in-human clinical study following a prearranged two-patient safety and performance review Study is investigating...Invizius Announces Appointment of World-Renowned Nephrologist Professor Bernard Canaud to its Clinical Advisory Board
GLASGOW, Scotland, Oct. 24, 2023 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, is pleased to announce the appointment of Professor Bernard Canaud to its Clinical Advisory Board. Professor Canaud is a...Invizius Receives MHRA Approval to Commence First-in-Human Clinical Study of H-Guard® Priming Solution
H-Guard® will be evaluated for its safety and efficacy to address serious complement driven complications of haemodialysis GLASGOW, Scotland, Aug. 1, 2023 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies for a range of...Invizius announces 'Angry Blood' Haemodialysis Study and recruits its 300th patient
Novel study is investigating dysregulation of the complement system during standard hemodialysis therapy in relation to patient health outcomes. GLASGOW, Scotland, June 13, 2023 /PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Invizius
Sign Up For FreeTo access detailed company insights
Invizius Limited is a late pre-clinical-stage biotechnology company developing treatments to suppress unwanted innate immune responses, focused initially on reducing the life-threatening inflammatory effects of dialysis.... Read More
